Pancreatic pseudocyst and walled-off necrosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients between 18 and 75 years old, regardless of gender; 2. Patients with pancreatic pseudocyst or encapsulated necrosis diagnosed by enhanced CT; 3. Patients with PFC diameter >= 6cm; 4. The subjects who can understand the purpose of the trial voluntarily participate and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with poor general condition, who can't tolerate endoscopy or have contraindications of endoscopic drainage, such as patients with acute inflammation and ulcer of upper digestive tract after digestive tract reconstruction, upper digestive tract stenosis and obstruction, and those who can't pass endoscopy; 2. The patients whose cysts are close to the great vessels, especially those with aneurysms, intracapsular hemorrhage, rupture of cysts, varicose veins of cardia and gastric fundus, and suspicious canceration; 3. Patients with coagulation dysfunction or bleeding tendency; 4. For patients with severe lung or heart disease; 5. Patients with allergic history to nitinol; 6. Pregnant and lactating women and subjects who are going to be pregnant in the near future; 7. Subjects who participated in clinical trials of any drug and / or medical device within 3 months before enrollment; 8. The researchers believe that there are any other factors that are not suitable for inclusion or affect the subjects' participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drainage success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Technical success rate; | — |
Countries
China
Contacts
Shanghai Changhai Hospital